Oriental Aromatics: Unaudited Financial Results for the Quarter Ended 30th September, 2026
Oriental Aromatics (OAL) filed a disclosure titled "Unaudited Financial Results for the Quarter Ended 30th September, 2026". The company is valued at about ₹1,904 crore.
What happened
Oriental Aromatics (OAL) filed a disclosure with the exchanges on 4 November 2026 at 05:47 PM titled "Unaudited Financial Results for the Quarter Ended 30th September, 2026".
Company snapshot
Oriental Aromatics is a small-cap company, with a market value of about ₹1,904 crore.
The stock last traded at ₹565.9, against a 52-week range of ₹228–₹645 (12.3% below the high).
Before this filing the shares had moved +5.2% over the month and +47.2% over three months. Average daily turnover over the last 20 sessions was about ₹15.86 crore.
Promoters held 74.17% at the end of Q1 FY27. Foreign institutions owned 0.02% and domestic institutions 0.00%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 226 | 0.5 | 0.15 |
| Q2 FY26 | 271 | 0.7 | 0.22 |
| Q3 FY26 | 252 | -1.9 | -0.57 |
| Q4 FY26 | 282 | 4 | 1.18 |
| Q1 FY27 | 260 | 2.5 | 0.75 |
What history shows
BCEIE's records show 1 previous results filing from the company since May 2026.
Market-wide, 10,609 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 4 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- Oriental Aromatics enters strategic manufacturing deal with Unilever
- Oriental Aromatics Limited (OAL.NS) Seasonal Returns Chart - Yahoo Finance
- Oriental Aromatics surges on entering into arrangement with Unilever Industries
- Oriental Aromatics OAL Q2 FY27 Earnings Conference Call
- Oriental Aromatics Announces Special Window for Physical Share Transfers
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.